Sanofi’s Isatuximab Added to RVd Boosts Response in Multiple Myeloma
Summary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…
Summary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…
Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell therapy for the treatment of relapsed or…
Keypoints Dr. Reddy’s Laboratories said it has received approval from the US health regulator to market Lenalidomide capsules, used to treat multiple…